Effectiveness, Efficacy, and Safety of XGEVA (denosumab) in Chinese Patients With Giant Cell Tumor of Bone (GCTB): A Systematic Literature Review (20220044) First published 28/09/2022 Last updated 05/12/2023 EU PAS number:EUPAS49061 Study Finalised